Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.333SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.54SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
DR.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.5.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.59SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CA.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
ED.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CM.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.56SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDP.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HN.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.24.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-14335.1Singapore
FL.1.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HE.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EE.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BW.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KB.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HF.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.42.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.517SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.427 (Epsilon)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.429 (Epsilon)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.166SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
A.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.7.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used